GLP-1 medications do not work for everyone, and genomics may hold the key to understanding why. Dr. Robert C. Green comments on a new study published in Nature that revealed two genes involved in gut and appetite suppression. Pointing to the promise of personalized medicine, he further lays out a future where genomics is incorporated into every patient encounter to improve routine clinical care.
